TAP
CVS icon

Tounjian Advisory Partners’s CVS Health CVS Stock Holding History

Tounjian Advisory Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$135K Sell
1,304
-17,640
-93% -$1.57M 0.06% 149
2026
Q1 		$1.36M Buy
18,944
+2,620
+16% +$202K 0.49% 76
2025
Q4 		$1.3M Sell
16,324
-612
-4% -$48.2K 0.44% 81
2025
Q3 		$1.28M Buy
+16,936
New +$1.16M 0.43% 81

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Tounjian Advisory Partners's CVS Position: Q2 2026 in Review

Tounjian Advisory Partners reduced its CVS Health (CVS) stake by 93% in Q2 2026, selling an estimated $1.57M and leaving 1,304 shares worth $135K. The position accounts for 0.06% of the portfolio, ranked #149.

Tounjian Advisory Partners first reported a position in CVS in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.36M in Q1 2026. 2,071 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Tounjian Advisory Partners held 1,304 shares of CVS Health worth $135K as of Q2 2026.
  • Tounjian Advisory Partners sold 17,640 CVS Health shares in Q2 2026, an estimated $1.57M.
  • CVS Health made up 0.06% of Tounjian Advisory Partners's portfolio in Q2 2026, its #149 holding.
  • Tounjian Advisory Partners first reported a position in CVS Health in Q3 2025 and has held it in 4 quarters since.
  • Tounjian Advisory Partners's CVS Health position peaked at $1.36M in Q1 2026.
  • 2,071 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Tounjian Advisory Partners's 13F filing for Q2 2026, filed 7 Aug 2026.